Tagged with CIS

A European Approach to Enable Equal Access to Precision Oncology
Josep Tabernero – Director, Vall d’Hebron Institute of Oncology (VHIO)
Dun Yang – President & CEO, Anticancer Bioscience
Sizhen Wang – CEO & Co-Founder, Genetron Health
Gideon Ho – Co-Founder & CEO, HistoIndex
Can Sweden take the lead in Precision Medicine?
China: Hitgen Aims to Strengthen its “Innovation Foundation” with UK & US Partnerships
Precision Medicine in Asia: More Regional Cooperation Needed
Reclaiming Asia’s Genomic Destiny
Jin LI – Chairman & CEO, HitGen, China
Jeong-Sun Seo – Chairman, Macrogen & President, KoreaBIO
Sangrae Cho – CEO, Gencurix
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here